Last updated: about 1 month ago
Evaxion Biotech A/S Reports Phase 2 Trial Extension for EVX-01 Vaccine
Evaxion Biotech A/S files Form 6-K on Feb 25, 2025, announcing an extension of its EVX-01 cancer vaccine trial. Key for growth and market positioning in biotech.